Is red yeast rice a suitable alternative for statins?

Mayo Clinic Proceedings

Volumn 83, Issue 11, 2008, Pages 1294-

  Carter, Maia ^a   O'Keefe, James H ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ACETYLSALICYLIC ACID; CHOLESTIN; FISH OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ALTERNATIVE MEDICINE; BODY WEIGHT; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; DRUG COST; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; EXERCISE; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; LIFESTYLE MODIFICATION; MYALGIA; OBESITY; PRESCRIPTION; PROGNOSIS; VITAMIN D DEFICIENCY;

EID: 55549102350     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.11.1294     Document Type: Letter

References (8)

1. Becker DJ, Gordon RY, Morris PB, et al. Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial. Mayo Clin Proc. 2008;83(7):758-764.
2. O'Keefe JH, Bybee KA, Lavie CJ. Intensive lipid intervention in the post-ENHANCE era [editorial]. Mayo Clin Proc. 2008;83(8):867-869.
3. Bybee KA, Lee JH, O'Keefe JH. Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin. Curr Med Res Opin. 2008 Apr;24(4):1217-1229. Epub 2008 Mar 20. doi:10.1185/030079908X292001.
4. Lee JH, O'Keefe JH, Bell DH, Hensrud DD, Holick MF. Vitamin D deficiency: an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. In press.
5. Backes JM, Moriarty PM, Ruisinger JF, Gibson CA. Effects of once weekly rosuvastatin among patients with a prior statin intolerance. Am J Cardiol. 2007 Aug 1;100(3):554-555. Epub 2007 Jun 18. doi:10.1016/j.amjcard. 2007.03.059.
6. Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc. 2008;83(3):324-332.
7. Yokoyama M, Origasa H, Matsuzaki M, et al; Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis [pubished correction appears in Lancet. 2007;370(9583):220]. Lancet. 2007;369:1090-1098. doi:10.1016/S0140- 6736(07)60527-3.
8. O'Keefe JH, Gheewala NM, O'Keefe JO. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol. 2008;51(3):249-255. doi:10.1016/j.jacc.2007.10.016.